Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
McGrath RentCorp
MGRC
$2.83B
| $446K | ﹤0.01% |
6,200
-1,228
| -17% | -$90.3K |
|
3627
Ubiquiti
UI
$33.5B
| $445K | ﹤0.01% |
1,489
-501
| -25% | -$155K |
|
|
KDNY
3628
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $445K | ﹤0.01% |
34,884
-7,648
| -18% | -$101K |
|
3629
Fusion Fuel Green
HTOO
$18.8M
| $444K | ﹤0.01% |
1,169
+49
| +4% | +$21.7K |
|
|
CNBKA
3630
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $444K | ﹤0.01% |
3,857
+3,448
| +843% | +$395K |
|
3631
ADT
ADT
$5.62B
| $443K | ﹤0.01% |
54,912
+8,261
| +18% | +$76.1K |
|
3632
PROG Holdings
PRG
$1.71B
| $443K | ﹤0.01% |
10,559
-1,359
| -11% | -$61K |
|
|
MCF
3633
DELISTED
Contango Oil & Gas Co.
MCF
| $443K | ﹤0.01% |
96,875
+4,406
| +5% | +$16.8K |
|
3634
Alkami Technology
ALKT
$1.94B
| $442K | ﹤0.01% |
17,891
+59
| +0.3% | +$1.76K |
|
3635
Pilgrim's Pride
PPC
$6.56B
| $442K | ﹤0.01% |
15,157
-7,736
| -34% | -$194K |
|
3636
Hamilton Lane
HLNE
$4.91B
| $440K | ﹤0.01% |
5,188
+613
| +13% | +$54.9K |
|
3637
Lands' End
LE
$371M
| $440K | ﹤0.01% |
18,709
+8,752
| +88% | +$301K |
|
3638
Aclaris Therapeutics
ACRS
$722M
| $438K | ﹤0.01% |
24,343
+15,330
| +170% | +$246K |
|
3639
West Fraser Timber
WFG
$5.02B
| $437K | ﹤0.01% |
5,196
-11,657
| -69% | -$869K |
|
3640
International Bancshares
IBOC
$4.74B
| $435K | ﹤0.01% |
10,454
-16,246
| -61% | -$663K |
|
3641
PUT
Peloton Interactive
PTON
$2.75B
| $435K | ﹤0.01% |
5,000
| – | – |
|
3642
PJT Partners
PJT
$4.36B
| $434K | ﹤0.01% |
5,485
-1,898
| -26% | -$145K |
|
|
HNGR
3643
DELISTED
Hanger Inc.
HNGR
| $433K | ﹤0.01% |
19,717
-1,391
| -7% | -$32.2K |
|
3644
Vanguard S&P 500 Growth ETF
VOOG
$25.8B
| $432K | ﹤0.01% |
9,714
-39,426
| -80% | -$1.81M |
|
|
PFC
3645
DELISTED
Premier Financial Corp. Common Stock
PFC
| $432K | ﹤0.01% |
13,583
+159
| +1% | +$4.59K |
|
3646
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
| $431K | ﹤0.01% |
13,099
-3,942
| -23% | -$132K |
|
3647
OraSure Technologies
OSUR
$274M
| $431K | ﹤0.01% |
38,106
-1,646
| -4% | -$18.1K |
|
3648
SiriusPoint
SPNT
$2.73B
| $431K | ﹤0.01% |
46,587
+3,896
| +9% | +$37.4K |
|
3649
HealthStream
HSTM
$810M
| $430K | ﹤0.01% |
15,039
+727
| +5% | +$21.2K |
|
|
CCRN
3650
DELISTED
Cross Country Healthcare
CCRN
| $429K | ﹤0.01% |
20,183
+1,425
| +8% | +$26.7K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.